Literature DB >> 22343225

Ovarian cancer: etiology, risk factors, and epidemiology.

Jessica Hunn1, Gustavo C Rodriguez.   

Abstract

Little is known regarding the early aspects of ovarian carcinogenesis. As a consequence, the identification of women at risk for the disease is based primarily on clinical grounds, with family history being the most important risk factor. In this review, we will discuss the various hypotheses regarding ovarian etiology and pathogenesis. In addition, we will discuss the epidemiology of ovarian cancer, including hereditary, reproductive, hormonal, inflammatory, dietary, surgical, and geographic factors that influence ovarian cancer risk.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22343225     DOI: 10.1097/GRF.0b013e31824b4611

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  108 in total

1.  Over-the-counter treatments and perineal hygiene in postmenopausal women.

Authors:  Elisabeth A Erekson; Deanna K Martin; E Christine Brousseau; Sallis O Yip; Terri R Fried
Journal:  Menopause       Date:  2014-03       Impact factor: 2.953

2.  Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer.

Authors:  Stacey J Winham; Sebastian M Armasu; Mine S Cicek; Melissa C Larson; Julie M Cunningham; Kimberly R Kalli; Brooke L Fridley; Ellen L Goode
Journal:  Genet Epidemiol       Date:  2014-05-22       Impact factor: 2.135

3.  Exploring the HYDRAtion method for loading siRNA on liposomes: the interplay between stability and biological activity in human undiluted ascites fluid.

Authors:  George R Dakwar; Kevin Braeckmans; Wim Ceelen; Stefaan C De Smedt; Katrien Remaut
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

4.  Associations of a Healthy Lifestyle Index With the Risks of Endometrial and Ovarian Cancer Among Women in the Women's Health Initiative Study.

Authors:  Rhonda Arthur; Theodore M Brasky; Tracy E Crane; Ashley S Felix; Andrew M Kaunitz; Aladdin H Shadyab; Lihong Qi; Sylvia Wassertheil-Smoller; Thomas E Rohan
Journal:  Am J Epidemiol       Date:  2019-02-01       Impact factor: 4.897

5.  Unbalanced estrogen metabolism in ovarian cancer.

Authors:  Muhammad Zahid; Cheryl L Beseler; James B Hall; Tricia LeVan; Ercole L Cavalieri; Eleanor G Rogan
Journal:  Int J Cancer       Date:  2014-01-25       Impact factor: 7.396

6.  Validation of family cancer history data in high-risk families: the influence of cancer site, ethnicity, kinship degree, and multiple family reporters.

Authors:  Parisa Tehranifar; Hui-Chen Wu; Tom Shriver; Ann J Cloud; Mary Beth Terry
Journal:  Am J Epidemiol       Date:  2015-01-07       Impact factor: 4.897

7.  The Asn680Ser polymorphism of the follicle stimulating hormone receptor gene and ovarian cancer risk: a meta-analysis.

Authors:  Xue Qin; Liping Ma; Shi Yang; Jianyang Zhao; Siyuan Chen; Yantong Xie; Jian Wang; Taijie Li; Yu He; Qiliu Peng; Yan Deng; Shan Li; Aiping Qin
Journal:  J Assist Reprod Genet       Date:  2014-06       Impact factor: 3.412

8.  Endometriosis and ovarian cancer.

Authors:  Milena Králíčková; Vaclav Vetvicka
Journal:  World J Clin Oncol       Date:  2014-12-10

9.  Casticin inhibits the epithelial-mesenchymal transition in ovarian carcinoma via the hedgehog signaling pathway.

Authors:  Jing Zhang; Yinghong Cui; Shuwen Sun; Jianguo Cao; Xiaoling Fang
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

10.  The novel estrogen receptor GPER regulates the migration and invasion of ovarian cancer cells.

Authors:  Yan Yan; Huidi Liu; Haixia Wen; Xueli Jiang; Xuefeng Cao; Guangmei Zhang; Guoyi Liu
Journal:  Mol Cell Biochem       Date:  2013-04-12       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.